Kineticos Ventures has been busy investing as well. In late May, eXmoor pharma, a UK cell and gene therapy manufacturer partner closed on a $35 million Series A round of funding from Kineticos and one other.
Read More
Kincell Bio, a new company formed to develop and manufacture cell therapies for biotechnology companies, may be based in Florida, but it has North Carolina fingerprints all over it. And also management has lots of new cash.
Read More
Dr. Matthias Schroff is the new CEO at Inceptor Bio, a startup focusing on therapies for what the company calls “difficult-to-treat” cancers.
Read More
Morrisville-based Inceptor Bio has a new partner, the University of Minnesota to create a new cell-based tool to fight difficult-to-treat cancers.
Read More
Cell and gene therapy startup Inceptor Bio, which raised $26 million in seed capital not long ago, has added more than $37 million in Series A funding.
Read More
The Raleigh-based gene editing startup Inceptor Bio, which aims to address the existing challenges in oncology, has raised more than $37.7 million.
Read More
Inceptor Bio continues to quickly advance its oncology product pipeline, acquiring a production plant in Florida. A team of employees at the site also will become part of the Inceptor Bio team.
Read More
The Raleigh-based startup with a goal to spin out 20 subsidiary companies in 20 years, announced it launched an advanced manufacturing platform using cell- and gene-based therapies to treat cancers.
Read More
The Raleigh-based firm identifies, incubates and accelerates novel technologies to advance progress for curing cancer and neurodegenerative diseases.
Read More
